Scientific Committee on Emerging and Newly-Identified Health Risks

The European Commission's Scientific Committee on Emerging and Newly-Identified Health Risks - SCENIHR - provides opinions on questions concerning emerging or newly identified risks and on broad, complex or multidisciplinary issues requiring a comprehensive assessment of risks to consumer safety or public health and related issues not covered by other Community risk assessment bodies. Examples of potential areas of activity include potential risks associated with interaction of risk factors, synergic effects, cumulative effects, antimicrobial resistance, new technologies such as nanotechnologies, medical devices including those incorporating substances of animal and/or human origin, tissue engineering, blood products, fertility reduction, cancer of endocrine organs, physical hazards such as noise and electromagnetic fields (from mobile phones, transmitters and electronically controlled home environments), and methodologies for assessing new risks.

The link address is: http://ec.europa.eu/health/ph_risk/committees/04_scenihr/04_scenihr_en.htm